1. Home
  2. NCNO vs IRON Comparison

NCNO vs IRON Comparison

Compare NCNO & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nCino Inc.

NCNO

nCino Inc.

HOLD

Current Price

$23.38

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$93.29

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCNO
IRON
Founded
2011
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.4B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NCNO
IRON
Price
$23.38
$93.29
Analyst Decision
Buy
Strong Buy
Analyst Count
17
12
Target Price
$33.40
$108.83
AVG Volume (30 Days)
2.2M
533.0K
Earning Date
12-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$586,485,000.00
N/A
Revenue This Year
$10.88
N/A
Revenue Next Year
$8.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.14
N/A
52 Week Low
$18.75
$30.82
52 Week High
$40.29
$97.12

Technical Indicators

Market Signals
Indicator
NCNO
IRON
Relative Strength Index (RSI) 35.75 62.09
Support Level $24.12 $87.18
Resistance Level $27.50 $96.18
Average True Range (ATR) 0.98 3.86
MACD -0.03 -0.36
Stochastic Oscillator 0.93 63.81

Price Performance

Historical Comparison
NCNO
IRON

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: